icatibant

Poland

Drugs containing this active substance

  • ICATIBANT FRESENIUS

    The medicine is used to treat the symptoms of hereditary angioedema (HAE) in adults and children and adolescents over 2 years of age. It helps to stop the development of attack symptoms, such as swelling, pain, nausea, and diarrhea.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant 30 mg

    ATC: B06AC02

    Manufacturer: Fresenius Kabi Austria GmbH

  • IDANUZ

    The medicine is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and adolescents and children aged 2 years and older.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant 10 mg/ml

    ATC: B06AC02

    Manufacturer: Eurofins Proxy Laboratories B.V. Pharmadox Healthcare Ltd.

  • IKATYBANT RANBAXY

    The medicine is intended for the treatment of symptoms of hereditary angioedema (HAE) in adults and adolescents and children aged 2 years and older. It helps to stop the development of attack symptoms, such as swelling, pain, nausea, and diarrhea.

    Form: solution for injection in ampoule-syringe

    Active substance Dosage
    icatibant 30 mg

    ATC: B06AC02

    Manufacturer: Eurofins Proxy Laboratories BV Pharmadox Healthcare Ltd. Terapia S.A.